Marcus Norris

Marcus Norris is an accomplished scientist with significant experience in the biopharmaceutical industry. Currently serving as Scientist II at BioAgilytix since August 2024, Marcus previously held roles such as Scientist I at Benecyte, Inc. and CoImmune, Inc., where contributions included tech transfer collaborations and development of cell culture methods for CAR cytokine induced killer cells. Prior to that, at Argos Therapeutics, Marcus advanced through several positions, culminating as Senior Research Associate I, contributing to the tech transfer and clinical trial support that generated substantial revenue for the company. Marcus holds a Master of Science in Biology from East Carolina University and a Bachelor of Science in Biology from the University of North Carolina at Chapel Hill.